Skinvisible Statistics
Total Valuation
Skinvisible has a market cap or net worth of 972,692. The enterprise value is 6.83 million.
| Market Cap | 972,692 |
| Enterprise Value | 6.83M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Skinvisible has 5.40 million shares outstanding. The number of shares has decreased by -6.08% in one year.
| Current Share Class | 5.40M |
| Shares Outstanding | 5.40M |
| Shares Change (YoY) | -6.08% |
| Shares Change (QoQ) | -5.43% |
| Owned by Insiders (%) | 3.52% |
| Owned by Institutions (%) | n/a |
| Float | 5.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 48.63 |
| PB Ratio | -0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 253.44 |
| P/OCF Ratio | 253.44 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1,780.00 |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 1,527.60 |
| Interest Coverage | -0.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -215.11% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 8.48% |
| Weighted Average Cost of Capital (WACC) | 8.57% |
| Revenue Per Employee | 10,000 |
| Profits Per Employee | -515,660 |
| Employee Count | 2 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.73% in the last 52 weeks. The beta is 1.72, so Skinvisible's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | +11.73% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.36 |
| Relative Strength Index (RSI) | 43.94 |
| Average Volume (20 Days) | 3,341 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.14 |
Income Statement
In the last 12 months, Skinvisible had revenue of 20,000 and -1.03 million in losses. Loss per share was -0.19.
| Revenue | 20,000 |
| Gross Profit | 20,000 |
| Operating Income | -458,981 |
| Pretax Income | -1.03M |
| Net Income | -1.03M |
| EBITDA | -438,742 |
| EBIT | -458,981 |
| Loss Per Share | -0.19 |
Balance Sheet
The company has 3,959 in cash and 5.86 million in debt, with a net cash position of -5.86 million or -1.08 per share.
| Cash & Cash Equivalents | 3,959 |
| Total Debt | 5.86M |
| Net Cash | -5.86M |
| Net Cash Per Share | -1.08 |
| Equity (Book Value) | -10.79M |
| Book Value Per Share | -2.00 |
| Working Capital | -5.50M |
Cash Flow
| Operating Cash Flow | 3,838 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 20,239 |
| Net Borrowing | n/a |
| Free Cash Flow | 3,838 |
| FCF Per Share | 0.00 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,294.91% |
| Pretax Margin | -5,156.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 19.19% |
Dividends & Yields
Skinvisible does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.08% |
| Shareholder Yield | 6.08% |
| Earnings Yield | -106.03% |
| FCF Yield | 0.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 4, 2019. It was a reverse split with a ratio of 0.02.
| Last Split Date | Jan 4, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
Skinvisible has an Altman Z-Score of -537.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -537.02 |
| Piotroski F-Score | 3 |